Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.

Clinical epigenetics - 9 Nov 2024

Gao Qiang, Shen Kefeng, Xiao Min

Abstract excerpt

TET2 is a critical gene that regulates DNA methylation, encoding a dioxygenase protein that plays a vital role in the regulation of genomic methylation and other epigenetic modifications, as well as in hematopoiesis. Mutations in TET2 are present in 7%-28% of adult acute myeloid leukemia (AML) patients. Despite this, the precise mechanisms by which TET2 mutations contribute to malignant transformation and how...

Topics

Join the communities discussing this publication.

Clinical Relevance
Dioxygenases
DNA-Binding Proteins
DNA Methylation
Epigenesis, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Leukemia, Myeloid, Acute

Proto-Oncogene Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 39521964
DOI: 10.1186/s13148-024-01771-2
PMCID: PMC11550532

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.PMID 39521964Read ↗

TET2: A cornerstone in normal and malignant hematopoiesis.Semantic proximity Read ↗

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.Semantic proximity Read ↗

TET2 in Normal and Malignant Hematopoiesis.Semantic proximity Read ↗

TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.Semantic proximity Read ↗

Landscape of TET2 Mutations: From Hematological Malignancies to Solid TumorsSemantic proximity Read ↗

TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public databaseSemantic proximity Read ↗

TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.Semantic proximity Read ↗

Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.Semantic proximity Read ↗

Landscape of TET2 mutations in acute myeloid leukemiaSemantic proximity Read ↗

A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.Semantic proximity Read ↗

The TET2 interactors and their links to hematological malignancies.Semantic proximity Read ↗

Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.